✦ LIBER ✦

P-2 Assessment of comorbidity, simptoms and functional status in advanced non small cell lung cancer (ANSCLC) elderly patients treated with gemcitabine & vinorelbine

✍ Scribed by Maestu, Inmaculada; Mun˜oz, Jose; Lorenzo, Gómez-Aldaraví; Yubero, Alfonso; Torregrosa, Dolores; Esquerdo, Gaspar; Llorente, Rosa; Almenar, Daniel

Book ID: 118571703
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 159 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)91971-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Assessment of functional status, symptom

Assessment of functional status, symptoms and comorbidity in elderly patients with advanced non-small-cell lung cancer (NSCLC) treated with gemcitabine and vinorelbine

✍ I. Maestu; J. Muñoz; L. Gómez-Aldaraví; G. Esquerdo; A. Yubero; M. D. Torregrosa 📂 Article 📅 2007 🏛 Springer Milan 🌐 Spanish ⚖ 177 KB

Activity and toxicity of gemcitabine and

Activity and toxicity of gemcitabine and gemcitabine+vinorelbine in advanced non-small-cell lung cancer elderly patients

✍ Gridelli, Cesare; Cigolari, Silvio; Gallo, Ciro; Manzione, Luigi; Ianniello, Gio 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 81 KB

Combination chemotherapy of gemcitabine

Combination chemotherapy of gemcitabine and vinorelbine in patients with advanced non-small cell lung cancer

✍ BUYUKCELIK, A; UTKAN, G; YALCIN, B; DEMIRKAZIK, A 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Randomized study of vinorelbine–gemcitab

Randomized study of vinorelbine–gemcitabine versus vinorelbine–carboplatin in patients with advanced non-small cell lung cancer

✍ Tan, E.H.; Szczesna, A.; Krzakowski, M.; Macha, H.N.; Gatzemeier, U.; Mattson, K 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 179 KB

P-504 Phase II study of gemcitabine-vino

P-504 Phase II study of gemcitabine-vinorelbine followed by docetaxelin elderly patients with advanced non-small cell lung cancer

✍ José Luis, E.; Gaspar, E.; Sergio, V.; Eva, P.; Cristina, L.; Luis, L.; Margarit 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB

189 “Clinical benefit response” (CBR) us

189 “Clinical benefit response” (CBR) using cisplatin and gemcitabine in patients (pts) with advanced non-small cell lung cancer (ANSCLC)

✍ Monterubbianesi, M.C.; Mari, D.; Lippe, P.; Tummarello, D. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 148 KB